Telemedical care and quality of life in patients with schizophrenia and bipolar disorder: results of a randomized controlled trial
Abstract Background Schizophrenia and bipolar disorder are serious psychiatric disorders with a high disease burden, a high number of years of life lived with disability and a high risk for relapses and re-hospitalizations. Besides, both diseases are often accompanied with a reduced quality of life...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2021-06-01
|
| Series: | BMC Psychiatry |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12888-021-03318-8 |
| _version_ | 1818741084848652288 |
|---|---|
| author | Ulrike Stentzel Neeltje van den Berg Kilson Moon Lara N. Schulze Josephine Schulte Jens M. Langosch Wolfgang Hoffmann Hans J. Grabe |
| author_facet | Ulrike Stentzel Neeltje van den Berg Kilson Moon Lara N. Schulze Josephine Schulte Jens M. Langosch Wolfgang Hoffmann Hans J. Grabe |
| author_sort | Ulrike Stentzel |
| collection | DOAJ |
| description | Abstract Background Schizophrenia and bipolar disorder are serious psychiatric disorders with a high disease burden, a high number of years of life lived with disability and a high risk for relapses and re-hospitalizations. Besides, both diseases are often accompanied with a reduced quality of life (QoL). A low level of quality of life is one predictor for relapses. This study examines whether a telemedical care program can improve QoL. Methods Post stationary telemedical care of patients with severe psychiatric disorders” (Tecla) is a prospective controlled randomized intervention trial to implement and evaluate a telemedical care concept for patients with schizophrenia and bipolar disorder. Participants were randomized to an intervention or a control group. The intervention group received telemedical care including regular, individualized telephone calls and SMS-messages. QoL was measured with the German version of the WHOQOL-BREF. Effects of telemedicine on QoL after 6 months and treatment*time interactions were calculated using linear regressions (GLM and linear mixed models). Results One hundred eighteen participants were recruited, thereof 57.6% men (n = 68). Participants were on average 43 years old (SD 13). The treatment*time interaction was not significant. Hence, treatment had no significant effect either. Instead, gender is an influencing factor. Further analysis showed that social support, the GAF-level and QoL-values at baselines were significant determinants for the improvement of QoL. Conclusion The telemedicine care concept Tecla was not significant for QoL in patients with severe psychiatric disorders. More important for the QoL is the general social support and the level of global functioning of the patients. Trial registration German Clinical Trials Register, DRKS00008548, registered 21 May 2015 – retrospectively registered, https://www.drks.de/drks_web/setLocale_EN.do |
| first_indexed | 2024-12-18T01:51:00Z |
| format | Article |
| id | doaj.art-17a126f151e54cdebf58cc53059a66b3 |
| institution | Directory Open Access Journal |
| issn | 1471-244X |
| language | English |
| last_indexed | 2024-12-18T01:51:00Z |
| publishDate | 2021-06-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Psychiatry |
| spelling | doaj.art-17a126f151e54cdebf58cc53059a66b32022-12-21T21:25:02ZengBMCBMC Psychiatry1471-244X2021-06-0121111410.1186/s12888-021-03318-8Telemedical care and quality of life in patients with schizophrenia and bipolar disorder: results of a randomized controlled trialUlrike Stentzel0Neeltje van den Berg1Kilson Moon2Lara N. Schulze3Josephine Schulte4Jens M. Langosch5Wolfgang Hoffmann6Hans J. Grabe7University Hospital Greifswald, Institute for Community Medicine, Section Epidemiology of Health Care and Community HealthUniversity Hospital Greifswald, Institute for Community Medicine, Section Epidemiology of Health Care and Community HealthUniversity Hospital Greifswald, Institute for Community Medicine, Section Epidemiology of Health Care and Community HealthUniversity Hospital Greifswald, Clinic and Polyclinic for Psychiatry and PsychotherapyUniversity Hospital Greifswald, Clinic and Polyclinic for Psychiatry and PsychotherapyBethanien Hospital for Psychiatry, Psychosomatics and PsychotherapyUniversity Hospital Greifswald, Institute for Community Medicine, Section Epidemiology of Health Care and Community HealthUniversity Hospital Greifswald, Clinic and Polyclinic for Psychiatry and PsychotherapyAbstract Background Schizophrenia and bipolar disorder are serious psychiatric disorders with a high disease burden, a high number of years of life lived with disability and a high risk for relapses and re-hospitalizations. Besides, both diseases are often accompanied with a reduced quality of life (QoL). A low level of quality of life is one predictor for relapses. This study examines whether a telemedical care program can improve QoL. Methods Post stationary telemedical care of patients with severe psychiatric disorders” (Tecla) is a prospective controlled randomized intervention trial to implement and evaluate a telemedical care concept for patients with schizophrenia and bipolar disorder. Participants were randomized to an intervention or a control group. The intervention group received telemedical care including regular, individualized telephone calls and SMS-messages. QoL was measured with the German version of the WHOQOL-BREF. Effects of telemedicine on QoL after 6 months and treatment*time interactions were calculated using linear regressions (GLM and linear mixed models). Results One hundred eighteen participants were recruited, thereof 57.6% men (n = 68). Participants were on average 43 years old (SD 13). The treatment*time interaction was not significant. Hence, treatment had no significant effect either. Instead, gender is an influencing factor. Further analysis showed that social support, the GAF-level and QoL-values at baselines were significant determinants for the improvement of QoL. Conclusion The telemedicine care concept Tecla was not significant for QoL in patients with severe psychiatric disorders. More important for the QoL is the general social support and the level of global functioning of the patients. Trial registration German Clinical Trials Register, DRKS00008548, registered 21 May 2015 – retrospectively registered, https://www.drks.de/drks_web/setLocale_EN.dohttps://doi.org/10.1186/s12888-021-03318-8Telemedical careTelemedicineSchizophreniaBipolar disorderQuality of lifeWHOQOL-BREF |
| spellingShingle | Ulrike Stentzel Neeltje van den Berg Kilson Moon Lara N. Schulze Josephine Schulte Jens M. Langosch Wolfgang Hoffmann Hans J. Grabe Telemedical care and quality of life in patients with schizophrenia and bipolar disorder: results of a randomized controlled trial BMC Psychiatry Telemedical care Telemedicine Schizophrenia Bipolar disorder Quality of life WHOQOL-BREF |
| title | Telemedical care and quality of life in patients with schizophrenia and bipolar disorder: results of a randomized controlled trial |
| title_full | Telemedical care and quality of life in patients with schizophrenia and bipolar disorder: results of a randomized controlled trial |
| title_fullStr | Telemedical care and quality of life in patients with schizophrenia and bipolar disorder: results of a randomized controlled trial |
| title_full_unstemmed | Telemedical care and quality of life in patients with schizophrenia and bipolar disorder: results of a randomized controlled trial |
| title_short | Telemedical care and quality of life in patients with schizophrenia and bipolar disorder: results of a randomized controlled trial |
| title_sort | telemedical care and quality of life in patients with schizophrenia and bipolar disorder results of a randomized controlled trial |
| topic | Telemedical care Telemedicine Schizophrenia Bipolar disorder Quality of life WHOQOL-BREF |
| url | https://doi.org/10.1186/s12888-021-03318-8 |
| work_keys_str_mv | AT ulrikestentzel telemedicalcareandqualityoflifeinpatientswithschizophreniaandbipolardisorderresultsofarandomizedcontrolledtrial AT neeltjevandenberg telemedicalcareandqualityoflifeinpatientswithschizophreniaandbipolardisorderresultsofarandomizedcontrolledtrial AT kilsonmoon telemedicalcareandqualityoflifeinpatientswithschizophreniaandbipolardisorderresultsofarandomizedcontrolledtrial AT laranschulze telemedicalcareandqualityoflifeinpatientswithschizophreniaandbipolardisorderresultsofarandomizedcontrolledtrial AT josephineschulte telemedicalcareandqualityoflifeinpatientswithschizophreniaandbipolardisorderresultsofarandomizedcontrolledtrial AT jensmlangosch telemedicalcareandqualityoflifeinpatientswithschizophreniaandbipolardisorderresultsofarandomizedcontrolledtrial AT wolfganghoffmann telemedicalcareandqualityoflifeinpatientswithschizophreniaandbipolardisorderresultsofarandomizedcontrolledtrial AT hansjgrabe telemedicalcareandqualityoflifeinpatientswithschizophreniaandbipolardisorderresultsofarandomizedcontrolledtrial |